Edwards Lifesciences (EW) Return on Invested Capital (2010 - 2018)

Edwards Lifesciences' (EW) quarterly Return on Invested Capital came in at 0.01% in Q4 2018, down 8.0% year-on-year from 0.01% in Q4 2017, and up 6.81% quarter-over-quarter from 0.01% in Q3 2018.

Edwards Lifesciences (EW) Return on Invested Capital (2010 - 2018) Analysis & Trends

Edwards Lifesciences' Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.01% for Q4 2018.

  • On a quarterly basis, Return on Invested Capital fell 8.0% year-over-year to 0.01% in Q4 2018; TTM through Dec 2018 was 0.01%, a 8.0% decrease from a year earlier, with the FY2012 full-year figure at 0.02%, up 12.0% from the prior year.
  • Return on Invested Capital grew to 0.01% in Q4 2018 per EW's latest filing, from 0.01% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.09% in Q4 2017 and bottomed at 0.01% in Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 0.01%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 0.01%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 0.01%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 0.00%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 0.00%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 0.07%

Historic Data

Download Data
DateValue
Dec 31, 2018 0.01%
Sep 30, 2018 0.01%
Jun 30, 2018 0.01%
Mar 31, 2018 0.01%
Dec 31, 2017 0.09%
Sep 30, 2013 0.02%
Jun 30, 2013 0.02%
Mar 31, 2013 0.02%
Dec 31, 2012 0.02%
Sep 30, 2012 -0.01%
Jun 30, 2012 -0.03%
Mar 31, 2012 -0.03%
Dec 31, 2011 -0.02%
Sep 30, 2011 0.00%
Jun 30, 2011 0.00%
Mar 31, 2011 0.00%
Dec 31, 2010 0.00%
Sep 30, 2010 0.01%
Jun 30, 2010 0.08%